Prime Medicine, Inc. (PRME)
USD 1.19
(-8.85%)
USD 1.19
(-8.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -147.9 Million USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 100.0% |
| 2019 | -2.76 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2024 Q2 | 37.77 Million USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | - USD | -39.97% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | - USD | -193.35% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 288.66% |
| 2020 Q4 | - USD | 0.0% |
| 2019 FY | -2.76 Million USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 109.744% |
| AlloVir, Inc. | -398 Thousand USD | -37062.06% |
| Aptorum Group Limited | -1.11 Million USD | -13168.735% |
| Ardelyx, Inc. | 106.66 Million USD | 238.668% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 161.439% |
| Bicycle Therapeutics plc | -129.52 Million USD | -14.195% |
| AbCellera Biologics Inc. | 38.02 Million USD | 488.968% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 123354.167% |
| Chimerix, Inc. | 324 Thousand USD | 45749.691% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -374.546% |
| Elevation Oncology, Inc. | -39 Thousand USD | -379143.59% |
| Alkermes plc | 1.37 Billion USD | 110.759% |
| Fortress Biotech, Inc. | 57.85 Million USD | 355.657% |
| Fortress Biotech, Inc. | 57.85 Million USD | 355.657% |
| Agenus Inc. | 139.61 Million USD | 205.938% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 992.23% |
| Dyadic International, Inc. | 922.95 Thousand USD | 16125.124% |
| ImmuCell Corporation | 4.39 Million USD | 3464.319% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 802.27% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -39.371% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -84493.035% |
| Immix Biopharma, Inc. | -5468.00 USD | -2704819.532% |
| Incyte Corporation | 3.44 Billion USD | 104.299% |
| IO Biotech, Inc. | -756 Thousand USD | -19464.153% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -215.773% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -1007.252% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -334617.57% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -50.59% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -22174.849% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -268818.182% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2958000.0% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 223.508% |
| ContextLogic Inc. | 59 Million USD | 350.686% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 18542.02% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -27965.465% |
| MiMedx Group, Inc. | 266.84 Million USD | 155.428% |
| MEI Pharma, Inc. | 49.32 Million USD | 399.846% |
| Novavax, Inc. | 639.93 Million USD | 123.112% |
| NextCure, Inc. | -3.68 Million USD | -3914.794% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 876.69% |
| Onconetix, Inc. | -1.12 Million USD | -13021.859% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -410.581% |
| Opthea Limited | 21.72 Thousand USD | 681062.247% |
| Psyence Biomedical Ltd. | -240.00 USD | -61626983.333% |
| Vaxcyte, Inc. | -75 Million USD | -97.207% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -257906.838% |
| Precigen, Inc. | 106 Thousand USD | 139633.019% |
| Pharming Group N.V. | 220.1 Million USD | 167.198% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 28819.417% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 14758.573% |
| PureTech Health plc | -1.6 Million USD | -9126.762% |
| Pyxis Oncology, Inc. | -2 Million USD | -7295.25% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 234.738% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 18.468% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -28522.379% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 2204.81% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -226.321% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -572.693% |
| Acelyrin, Inc. | -115 Thousand USD | -128513.043% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1471445.12% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -25802.802% |
| Senti Biosciences, Inc. | -2.68 Million USD | -5412.672% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1979.113% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 3751.074% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2982.639% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -3651.984% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 607.759% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 29919.556% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 34983.255% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -180271.951% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 242.081% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 209.341% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -52.558% |
| ChromaDex Corporation | 50.78 Million USD | 391.266% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 603.301% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -63652.155% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -29961.992% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -90.604% |
| CRISPR Therapeutics AG | 240.95 Million USD | 161.383% |
| Precision BioSciences, Inc. | 40.47 Million USD | 465.45% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -50.673% |
| Innoviva, Inc. | 261.06 Million USD | 156.654% |
| Jaguar Health, Inc. | 7.72 Million USD | 2014.876% |
| Summit Therapeutics Inc. | -2.05 Million USD | -7114.878% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 3478.369% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 786.493% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -124723.826% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -103112.818% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 24386.535% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 222.769% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 147.153% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 5846.115% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -291395.861% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1983.756% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -31067.75% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1422063.462% |
| Soligenix, Inc. | 97.31 Thousand USD | 152092.067% |
| Century Therapeutics, Inc. | -10.8 Million USD | -1268.35% |
| Kura Oncology, Inc. | -849 Thousand USD | -17321.084% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -120.412% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -100515.646% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 249.34% |
| Autolus Therapeutics plc | -4.86 Million USD | -2938.936% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 457.379% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -87938.69% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 256.145% |
| GRI Bio, Inc. | 10.84 Million USD | 1464.311% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 5923.064% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1602.602% |
| IGM Biosciences, Inc. | -211.66 Million USD | 30.121% |
| INmune Bio, Inc. | 155 Thousand USD | 95522.581% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 338.791% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -9719.152% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -22708.865% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -505143.561% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 36892.289% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -7310.07% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -47153.994% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 256.578% |
| Verastem, Inc. | -62 Thousand USD | -238456.452% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 6174.127% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -56568.582% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 4986.191% |
| Histogen Inc. | 3.76 Million USD | 4024.25% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 25769.974% |
| Surrozen, Inc. | -27.23 Million USD | -443.169% |
| Organovo Holdings, Inc. | -5.38 Million USD | -2644.572% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -12175.496% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -476.695% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 837.607% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -7469849.495% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 2538.092% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -220222.951% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 195.551% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 101543.759% |
| Apollomics, Inc. | 127 Thousand USD | 116560.63% |
| Amarin Corporation plc | 165.54 Million USD | 189.346% |
| Mesoblast Limited | -9.81 Million USD | -1406.928% |
| Turnstone Biologics Corp. | 16.5 Million USD | 996.068% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -33.864% |
| Synaptogenix, Inc. | -6347.00 USD | -2330213.534% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -289909.804% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 191.659% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 108.415% |
| Better Therapeutics, Inc. | -2.72 Million USD | -5319.751% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -31.868% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 143.748% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1296402.454% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -2262.7% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -13248.827% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 2121.112% |
| Insmed Incorporated | 239.63 Million USD | 161.721% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 4233.734% |
| OmniAb, Inc. | 14.66 Million USD | 1108.42% |
| Alector, Inc. | -95.05 Million USD | -55.603% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 217.739% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -240.301% |
| Zai Lab Limited | 170.9 Million USD | 186.543% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 280.643% |
| Aura Biosciences, Inc. | -1.29 Million USD | -11321.236% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 113873.077% |
| Immunic, Inc. | -111 Thousand USD | -133147.748% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 1032.919% |
| Veracyte, Inc. | 248.14 Million USD | 159.604% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 97.884% |
| FibroGen, Inc. | 128.9 Million USD | 214.74% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -26224190.78% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -1167.733% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 104.352% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 38121.851% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 141.623% |
| TG Therapeutics, Inc. | 219.1 Million USD | 167.503% |
| Galecto, Inc. | -830 Thousand USD | -17719.88% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -10579.061% |
| Fortrea Holdings Inc. | 424 Million USD | 134.883% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -71.649% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -25985.538% |
| XBiotech Inc. | -1.74 Million USD | -8380.791% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -13248.827% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -218.274% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -95.812% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 301.497% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 980.23% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 138.018% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -197.913% |
| Vaxxinity, Inc. | -2.23 Million USD | -6520.636% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 145.265% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -1206.138% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 704.904% |
| NexImmune, Inc. | -1.02 Million USD | -14330.15% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 2739081.481% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1981.511% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 101.309% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -221225.213% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -4065.165% |
| Ainos, Inc. | -253.73 Thousand USD | -58191.59% |
| Pluri Inc. | 322 Thousand USD | 46033.23% |
| Prothena Corporation plc | -129.2 Million USD | -14.477% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 393.323% |
| Celularity Inc. | 6.75 Million USD | 2289.563% |
| Rallybio Corporation | -150 Thousand USD | -98503.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -353.599% |
| MeiraGTx Holdings plc | 287 Thousand USD | 51634.843% |
| Omeros Corporation | -69.77 Million USD | -111.962% |
| Humacyte, Inc. | -76.55 Million USD | -93.214% |
| Immunocore Holdings plc | 248.39 Million USD | 159.545% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -875.048% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 337.096% |
| Blueprint Medicines Corporation | 236.58 Million USD | 162.517% |
| CalciMedica, Inc. | -58 Thousand USD | -254908.621% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -10272.02% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 609.052% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -5100.598% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -379.2% |
| Pulmatrix, Inc. | -8.22 Million USD | -1699.331% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -12541.453% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -36968.922% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 62.912% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 5428.787% |
| Cytokinetics, Incorporated | -322.59 Million USD | 54.151% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 17256.263% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -43273.9% |
| Vor Biopharma Inc. | -3.49 Million USD | -4135.538% |
| Roivant Sciences Ltd. | 109.23 Million USD | 235.401% |
| Evogene Ltd. | 1.39 Million USD | 10672.194% |
| ProKidney Corp. | -3.16 Million USD | -4567.245% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -236.821% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 2256.993% |
| CorMedix Inc. | -205.56 Thousand USD | -71851.528% |
| BioLineRx Ltd. | 1.1 Million USD | 13448.827% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -88.004% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -448096.97% |
| Atai Life Sciences N.V. | -5000.00 USD | -2958000.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -121273.883% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -153967.708% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -10548.308% |
| Sagimet Biosciences Inc. | 2 Million USD | 7495.25% |
| MediciNova, Inc. | 979.7 Thousand USD | 15196.891% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -75.411% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -156322.188% |
| GeoVax Labs, Inc. | -20.72 Million USD | -613.801% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 160.484% |
| Biomea Fusion, Inc. | -4.2 Million USD | -3420.709% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 116.955% |
| Mereo BioPharma Group plc | 7.42 Million USD | 2091.718% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -47611.29% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -1232441.667% |
| Absci Corporation | -41.84 Million USD | -253.425% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2958000.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -93.661% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -5909.955% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 169.2% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -15617.853% |
| Allakos Inc. | -6.14 Million USD | -2308.484% |
| Imunon, Inc. | -720 Thousand USD | -20442.218% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -114.367% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 131.079% |
| BioAtla, Inc. | -103.73 Million USD | -42.585% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1296402.454% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -82992.697% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 39.088% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -47457.878% |
| XOMA Corporation | 3.86 Million USD | 3930.743% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -111.037% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 1099.763% |
| aTyr Pharma, Inc. | -2.38 Million USD | -6093.677% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1287.039% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -509917.241% |
| Viridian Therapeutics, Inc. | -1 Million USD | -14573.115% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 1137730869.231% |
| Akari Therapeutics, Plc | -4000.00 USD | -3697525.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 123.223% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 76062.467% |
| UroGen Pharma Ltd. | 73.35 Million USD | 301.637% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -454.076% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1274044.875% |
| Orgenesis Inc. | -5.72 Million USD | -2483.493% |
| Entera Bio Ltd. | -56 Thousand USD | -264016.071% |
| GH Research PLC | -315 Thousand USD | -46853.968% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -78156.614% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -28072.381% |
| Xencor, Inc. | -85.26 Million USD | -73.475% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -66832.305% |
| Replimune Group, Inc. | -2.65 Million USD | -5470.81% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -14672.242% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 183.166% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 76062.467% |
| Portage Biotech Inc. | -54 Thousand USD | -273798.148% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -156322.188% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -39132.095% |
| OncoCyte Corporation | 413 Thousand USD | 35912.349% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -3290333.815% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -66623773.874% |
| Purple Biotech Ltd. | -196 Thousand USD | -75361.735% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1749.253% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1612.012% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -1316.042% |
| HilleVax, Inc. | -2.15 Million USD | -6760.158% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -152379.381% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -985670.461% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -22041.467% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -642965.217% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1970348.272% |
| Savara Inc. | -44.26 Million USD | -234.158% |
| Curis, Inc. | 9.81 Million USD | 1607.543% |
| Daré Bioscience, Inc. | 2.76 Million USD | 5440.452% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -118425.018% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -8454.367% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -64770.614% |
| BeiGene, Ltd. | 2.07 Billion USD | 107.115% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -5190.068% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 62.993% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 360.911% |
| Erasca, Inc. | -3.73 Million USD | -3863.156% |
| bluebird bio, Inc. | -4.03 Million USD | -3570.099% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -524051.251% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 107.767% |
| DBV Technologies S.A. | 15.72 Million USD | 1040.393% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -524051.251% |
| Moderna, Inc. | 2.15 Billion USD | 106.863% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -16064.481% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1947.427% |
| Molecular Templates, Inc. | 50.39 Million USD | 393.491% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -27494.216% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 210.552% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -2277.13% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -275.937% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -33.094% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -4022.213% |
| MacroGenics, Inc. | 50.52 Million USD | 392.725% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -2325.467% |
| Aditxt, Inc. | -111.66 Thousand USD | -132360.147% |
| Adagene Inc. | 18.11 Million USD | 916.636% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 30408.402% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 205.494% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 193.708% |
| SciSparc Ltd. | 2.19 Million USD | 6835.2% |
| Vericel Corporation | 135.57 Million USD | 209.094% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -590362.693% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -477290.097% |
| Generation Bio Co. | -73.91 Million USD | -100.112% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -33745.538% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 370.794% |
| Invivyd, Inc. | -2.02 Million USD | -7193.146% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 50.836% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -142889.037% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 253.479% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 250.481% |
| ADMA Biologics, Inc. | 88.21 Million USD | 267.659% |
| Clene Inc. | 533 Thousand USD | 27849.531% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 713.48% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -15355.068% |
| GeoVax Labs, Inc. | -20.72 Million USD | -613.801% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 7539.889% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -76015.708% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 396.968% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1985.519% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -17591.986% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 277.312% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 202399.212% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 378.216% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 14.599% |
| Trevena, Inc. | 1.45 Million USD | 10265.292% |
| Surrozen, Inc. | -27.23 Million USD | -443.169% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -41799.433% |
| Cingulate Inc. | -582.91 Thousand USD | -25273.209% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -477012.903% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -650.825% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1953730.911% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -16688.309% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 121.728% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -14870.142% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -262412.868% |
| Kronos Bio, Inc. | 1.37 Million USD | 10880.248% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -175.603% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -50552.397% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -30188.912% |
| ImmunityBio, Inc. | -17.89 Million USD | -726.747% |
| Korro Bio, Inc. | -3.63 Million USD | -3974.518% |
| Kineta, Inc. | 5.43 Million USD | 2822.345% |
| BioVie Inc. | -229.37 Thousand USD | -64381.182% |
| Codexis, Inc. | 57.33 Million USD | 357.971% |
| Celularity Inc. | 6.75 Million USD | 2289.563% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 3785.647% |
| Celcuity Inc. | -142.77 Thousand USD | -103495.243% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 292460.15% |
| Cibus, Inc. | 1.42 Million USD | 10501.195% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -39446.791% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -545.338% |
| IN8bio, Inc. | -2.5 Million USD | -5813.834% |
| Kodiak Sciences Inc. | -25.94 Million USD | -470.027% |
| Annexon, Inc. | -3.26 Million USD | -4427.242% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -7136.057% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -254.374% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 23210.156% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 118.998% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 185.516% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -7684.474% |
| Arcellx, Inc. | 108.27 Million USD | 236.596% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -356.934% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 286.739% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -599.248% |
| Moolec Science SA | -143.3 Thousand USD | -103109.937% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -249.508% |
| Geron Corporation | -123.5 Million USD | -19.758% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 4599.696% |
| Royalty Pharma plc | 1.79 Billion USD | 108.245% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -111.022% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -4094722.813% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 64019.945% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -32.753% |
| Humacyte, Inc. | -76.55 Million USD | -93.214% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -15482.496% |
| 89bio, Inc. | -273 Thousand USD | -54077.656% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -11666.508% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -17341.627% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -120147.967% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 13317.605% |
| Notable Labs, Ltd. | 113 Thousand USD | 130989.381% |
| Liquidia Corporation | 14.6 Million USD | 1113.048% |
| Mustang Bio, Inc. | -2.22 Million USD | -6547.416% |
| Immunovant, Inc. | -231 Thousand USD | -63928.139% |
| Quantum-Si incorporated | 488 Thousand USD | 30408.402% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -166.212% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -492916.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 8043.34% |
| Acasti Pharma Inc. | -11 Thousand USD | -1344490.909% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -72183.828% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -22708.865% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 11.705% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 13136.101% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -38720.21% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -7453.882% |
| PepGen Inc. | -1.18 Million USD | -12391.976% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -116360.63% |
| United Therapeutics Corporation | 2.07 Billion USD | 107.145% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -545.958% |
| Solid Biosciences Inc. | -76.56 Million USD | -93.181% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -178998.604% |
| Immuneering Corporation | -764.13 Thousand USD | -19255.797% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 223305.662% |
| Belite Bio, Inc | -399 Thousand USD | -36968.922% |
| XOMA Corporation | 3.86 Million USD | 3930.743% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -638.196% |
| Bionomics Limited | -434.44 Thousand USD | -33944.272% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -13671.415% |
| uniQure N.V. | 2.21 Million USD | 6777.427% |
| Cassava Sciences, Inc. | -89.42 Million USD | -65.399% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -60.646% |
| Forte Biosciences, Inc. | -9000.00 USD | -1643288.889% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -17613.174% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -33745.538% |
| Altimmune, Inc. | -65.37 Million USD | -126.248% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 140.854% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -13671.415% |
| Compugen Ltd. | 31.45 Million USD | 570.211% |
| Peak Bio, Inc. | 367.76 Thousand USD | 40316.821% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 703.3% |
| Benitec Biopharma Inc. | 108 Thousand USD | 137049.074% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -189521.795% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -12194.68% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -8017.728% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -124189.916% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -12194.68% |
| Instil Bio, Inc. | -4.75 Million USD | -3009.861% |
| argenx SE | 1.1 Billion USD | 113.343% |
| Immunome, Inc. | -8.9 Million USD | -1560.548% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -7725.661% |
| Verona Pharma plc | -679.62 Thousand USD | -21662.769% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -84417.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | -6101.468% |
| CervoMed Inc. | -1.29 Million USD | -11333.358% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -6044.786% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2996.19% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 6085.633% |
| Moolec Science SA | -143.3 Thousand USD | -103109.937% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -36148.56% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -5436.345% |
| AnaptysBio, Inc. | 14.78 Million USD | 1100.643% |
| Design Therapeutics, Inc. | -537 Thousand USD | -27442.831% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -34538.173% |
| NeurAxis, Inc. | 2.15 Million USD | 6957.918% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 6992.125% |
| Lumos Pharma, Inc. | 2 Million USD | 7469.457% |
| Achilles Therapeutics plc | -4.73 Million USD | -3026.118% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -84417.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -139862.148% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 567.185% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 17256.263% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -14231.88% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -224.723% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 344065.116% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -17893.309% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -1123969.007% |
| Palisade Bio, Inc. | 246 Thousand USD | 60223.984% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -448096.97% |
| Beam Therapeutics Inc. | -59.67 Million USD | -147.863% |
| Neurogene Inc. | -3.26 Million USD | -4434.181% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 206.151% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -3906.094% |
| Sesen Bio, Inc. | 40 Million USD | 469.763% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -49699.663% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -3572.8% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1446.153% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 1150.462% |
| Athira Pharma, Inc. | -969 Thousand USD | -15163.674% |
| Vaccinex, Inc. | -16 Million USD | -824.175% |
| HCW Biologics Inc. | -574.82 Thousand USD | -25630.484% |
| XOMA Corporation | 3.86 Million USD | 3930.743% |
| Nektar Therapeutics | 53.47 Million USD | 376.572% |
| Arvinas, Inc. | 71.8 Million USD | 305.996% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -77.214% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -135.611% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -45833.23% |
| Rezolute, Inc. | -36 Thousand USD | -410747.222% |
| Clene Inc. | 533 Thousand USD | 27849.531% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -11518980.997% |
| BeyondSpring Inc. | 1.75 Million USD | 8546.887% |
| Synlogic, Inc. | -1.92 Million USD | -7587.37% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -399643.243% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -2235.834% |
| Peak Bio, Inc. | 367.76 Thousand USD | 40316.821% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -679.966% |
| Krystal Biotech, Inc. | 47.6 Million USD | 410.692% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 204.83% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 3043.383% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -5612.34% |
| MannKind Corporation | 136.19 Million USD | 208.601% |
| Ikena Oncology, Inc. | -50.49 Million USD | -192.928% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 235.925% |
| Gossamer Bio, Inc. | -4.38 Million USD | -3272.976% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -58592.46% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2958000.0% |
| Legend Biotech Corporation | 140.92 Million USD | 204.95% |
| Mural Oncology plc | -2.56 Million USD | -5661.784% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -26743.013% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -147805.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 812.658% |
| REGENXBIO Inc. | 53.02 Million USD | 378.913% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -2660.991% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -76783.691% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -8439.55% |
| Vaxart, Inc. | -60.76 Million USD | -143.413% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -56184.725% |
| Cellectis S.A. | 18 Thousand USD | 821794.444% |
| Longeveron Inc. | 221 Thousand USD | 67025.339% |
| Repare Therapeutics Inc. | -80.07 Million USD | -84.72% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 113.532% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -11330.062% |
| Revolution Medicines, Inc. | -399.66 Million USD | 62.993% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -422485.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 301946.939% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.718% |
| Denali Therapeutics Inc. | -93.34 Million USD | -58.45% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -590362.693% |
| Veru Inc. | 7.56 Million USD | 2054.882% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -97850.331% |
| Cingulate Inc. | -582.91 Thousand USD | -25273.209% |
| Passage Bio, Inc. | -3.72 Million USD | -3874.872% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -1227938.858% |
| Exicure, Inc. | -1.42 Million USD | -10293.886% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -38517.493% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 5571.883% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -28749.661% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 317.105% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -98762.353% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -149.814% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 37927.366% |
| OmniAb, Inc. | 14.66 Million USD | 1108.42% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 839.784% |
| Lipocine Inc. | -2.85 Million USD | -5088.16% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -7925.231% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -2492.55% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -9719.152% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 296.379% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -227446.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 275.459% |
| Ocugen, Inc. | -33.53 Million USD | -341.02% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -4577.577% |
| Q32 Bio Inc. | 578 Thousand USD | 25689.1% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -55713.208% |
| Alumis Inc. Common Stock | -1.28 Million USD | -11419.081% |
| Equillium, Inc. | 35.95 Million USD | 511.327% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -8564.616% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 29640.883% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -3577669.715% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -57006.178% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 35089.544% |
| Dominari Holdings Inc. | 2.03 Million USD | 7353.801% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -80514.92% |
| vTv Therapeutics Inc. | -13.59 Million USD | -987.937% |
| Bio-Techne Corporation | 773.07 Million USD | 119.132% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 954.004% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 132.098% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -12552.267% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -516.785% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1364.47% |
| Nkarta, Inc. | -5.86 Million USD | -2420.106% |
| BioCardia, Inc. | -7.24 Million USD | -1940.35% |
| Iterum Therapeutics plc | -1.75 Million USD | -8351.714% |